ALOVEXLABIALE*MAT CUT 3G 5%

AlovexLabiale 5% cutaneous stick
aciclovir

What it is and what it is used for
AlovexLabiale contains the active ingredient aciclovir.
It belongs to a group of medicines called "antivirals" that fight infections caused by viruses. AlovexLabiale is specifically active against herpes viruses, including the Herpes simplex virus.

AlovexLabiale is used to treat recurrent Herpes simplex virus infections of the lips (recurrent Herpes labialis) in adults and adolescents (over 12 years of age).

Consult your doctor if you do not feel better or if you feel worse after 10 days.

What you need to know before taking this medicine
Do not use AlovexLabiale:
- if you are allergic to the active ingredient or any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to another valaciclovir-based medicine;
- if you are a child under 12 years of age.

Warnings and precautions
Talk to your doctor or pharmacist before using AlovexLabiale.

AlovexLabiale should only be applied to Herpes simplex lesions on the lips; it is not recommended for application inside the mouth, in the eyes, nose, or vagina (mucous membranes) as it may cause irritation.
Do not use AlovexLabiale to treat genital herpes.
Take particular care to avoid accidental application to the eyes.

The use of the product, especially if prolonged, may cause allergic reactions. If this occurs, stop treatment and consult your doctor.
If you suffer from particularly severe recurrent herpes of the lips, consult your doctor.
If you suffer from herpes of the lips, avoid transmitting the virus, especially when small blisters (active lesions) are present (see paragraph Health education notes).
Do not use AlovexLabiale if you have a condition where your body's defence systems are not working well (AIDS or bone marrow transplant). In these cases, consult your doctor for the treatment of herpes of the lips and any other infection.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

Uncommon (may affect up to 1 in 100 people):
• transient burning or pain after application;
• moderate dryness or flaking of the skin;
• itching sensation.

Rare (may affect up to 1 in 1,000 people):
• irritation and redness of the skin (erythema);
• inflammation of the skin (contact dermatitis) after application.

Very rare (may affect up to 1 in 10,000 people)
• immediate allergic reactions including swelling of the face, lips, tongue and other parts of the body (angioedema) and urticaria.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.